Biotech Values

[rfj1862]

I have no position in SNUS, but speaking from the perspective of a catheterization lab, people get very excited over a 15-minute improvement in throughput. Beds are extremely expensive; the difference between a 15-20 minute and a 3-hour infusion is tremendous in terms of cost.

Even with noninferiority I suspect that there would be relatively rapid uptake if the difference in infusion times is that large. Not that that will do investors in SNUS any good tomorrow.